U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07529457) titled 'Akk09 in Adults With Constipation' on March 27.
Brief Summary: This randomized, double-blind, placebo-controlled trial will assess the clinical effects of Akk09 in adults with functional constipation. Participants will receive Akk09 or placebo for 4 weeks. The study will evaluate changes in bowel habits and symptom burden, as well as alterations in host inflammatory status, immune modulation, microbial ecosystem dynamics, neuroendocrine signaling related to the gut-brain axis, and systemic metabolic responses, to characterize the overall physiological impact of BC09 supplementation.
Study Start Date: May 01
Study Type: INTERVENTI...